000857586 001__ 857586
000857586 005__ 20210129235606.0
000857586 0247_ $$2doi$$a10.1177/1545968318812726
000857586 0247_ $$2ISSN$$a0888-4390
000857586 0247_ $$2ISSN$$a1545-9683
000857586 0247_ $$2ISSN$$a1552-6844
000857586 0247_ $$2pmid$$apmid:30444176
000857586 0247_ $$2WOS$$aWOS:000454134600005
000857586 0247_ $$2altmetric$$aaltmetric:52010640
000857586 037__ $$aFZJ-2018-06571
000857586 082__ $$a610
000857586 1001_ $$0P:(DE-HGF)0$$aBaumann, Alexander$$b0
000857586 245__ $$aNeural Correlates of Hypokinetic Dysarthria and Mechanisms of Effective Voice Treatment in Parkinson Disease
000857586 260__ $$aThousand Oaks, Calif.$$bSage$$c2018
000857586 3367_ $$2DRIVER$$aarticle
000857586 3367_ $$2DataCite$$aOutput Types/Journal article
000857586 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1547823580_30735
000857586 3367_ $$2BibTeX$$aARTICLE
000857586 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000857586 3367_ $$00$$2EndNote$$aJournal Article
000857586 520__ $$aBackground. Hypokinetic dysarthria is highly prevalent in idiopathic Parkinson disease (PD), and effectiveness of high-intensity voice treatment is well established. However, the neural correlates remain largely unknown. Objective. We aimed to specify cerebral pathophysiology of hypokinetic dysarthria and treatment-induced changes using functional magnetic resonance imaging (fMRI). Methods. We used fMRI to investigate healthy controls (HCs) and patients with idiopathic PD–associated dysarthria before and after treatment according to the Lee Silverman Voice Treatment LOUD (LSVT). During fMRI, participants covertly read sentences with normal (eg, conversation in a quiet room) or high (eg, shouting on a windy beach) intensity. In addition, we tested LSVT effects on intelligibility and different speech features (intensity, pitch, articulation). Results. LSVT effectively improved intelligibility, articulation, and pitch in patients. Covert high-intensity speech compared with covert normal-intensity speech led to increased activation of mainly secondary motor areas and bilateral superior and medial temporal regions. Prior to LSVT, patients showed less activity in several speech-associated areas compared with HCs. As a neural correlate of effective LSVT, increased right-sided superior temporal activity correlated with improved intelligibility. Conclusion. This is the first brain imaging study using a covert speech paradigm in PD, which revealed cortical hypoactivation as correlate of hypokinetic dysarthria. Furthermore, cortical correlates of effective LSVT treatment colocalized with the neuronal network, showing increased activation during high- versus normal-intensity speech generation.
000857586 536__ $$0G:(DE-HGF)POF3-572$$a572 - (Dys-)function and Plasticity (POF3-572)$$cPOF3-572$$fPOF III$$x0
000857586 588__ $$aDataset connected to CrossRef
000857586 7001_ $$0P:(DE-HGF)0$$aNebel, Adelheid$$b1
000857586 7001_ $$0P:(DE-HGF)0$$aGranert, Oliver$$b2
000857586 7001_ $$0P:(DE-HGF)0$$aGiehl, Kathrin$$b3
000857586 7001_ $$0P:(DE-HGF)0$$aWolff, Stephan$$b4
000857586 7001_ $$0P:(DE-HGF)0$$aSchmidt, Wiebke$$b5
000857586 7001_ $$0P:(DE-HGF)0$$aBaasch, Christin$$b6
000857586 7001_ $$0P:(DE-HGF)0$$aSchmidt, Gerhard$$b7
000857586 7001_ $$0P:(DE-HGF)0$$aWitt, Karsten$$b8
000857586 7001_ $$0P:(DE-HGF)0$$aDeuschl, Günther$$b9
000857586 7001_ $$0P:(DE-HGF)0$$aHartwigsen, Gesa$$b10
000857586 7001_ $$0P:(DE-HGF)0$$aZeuner, Kirsten E.$$b11
000857586 7001_ $$0P:(DE-Juel1)169110$$avan Eimeren, Thilo$$b12$$eCorresponding author
000857586 773__ $$0PERI:(DE-600)2100545-X$$a10.1177/1545968318812726$$gp. 154596831881272 -$$n12$$p1055 –1066$$tNeurorehabilitation and neural repair$$v32$$x1552-6844$$y2018
000857586 8564_ $$uhttps://juser.fz-juelich.de/record/857586/files/1545968318812726.pdf$$yRestricted
000857586 8564_ $$uhttps://juser.fz-juelich.de/record/857586/files/1545968318812726.pdf?subformat=pdfa$$xpdfa$$yRestricted
000857586 909CO $$ooai:juser.fz-juelich.de:857586$$pVDB
000857586 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)169110$$aForschungszentrum Jülich$$b12$$kFZJ
000857586 9131_ $$0G:(DE-HGF)POF3-572$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$v(Dys-)function and Plasticity$$x0
000857586 9141_ $$y2018
000857586 915__ $$0StatID:(DE-HGF)0410$$2StatID$$aAllianz-Lizenz
000857586 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000857586 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000857586 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000857586 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000857586 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000857586 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000857586 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000857586 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNEUROREHAB NEURAL RE : 2017
000857586 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000857586 920__ $$lyes
000857586 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
000857586 980__ $$ajournal
000857586 980__ $$aVDB
000857586 980__ $$aI:(DE-Juel1)INM-3-20090406
000857586 980__ $$aUNRESTRICTED